---
title: "BUZZ-Novo falls on U.S. President Trump's lower Ozempic price comments"
description: "Shares of Novo Nordisk fell approximately 5% following U.S. President Donald Trump's comments about lowering the price of Ozempic, the company's leading weight-loss drug. Analyst Per Hansen noted that"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/261567958.md"
published_at: "2025-10-17T07:31:51.000Z"
---

# BUZZ-Novo falls on U.S. President Trump's lower Ozempic price comments

> Shares of Novo Nordisk fell approximately 5% following U.S. President Donald Trump's comments about lowering the price of Ozempic, the company's leading weight-loss drug. Analyst Per Hansen noted that there was nothing new in Trump's statements and confirmed that price negotiations are ongoing, with results expected in the coming months. If the losses persist, it could mark Novo's worst trading day since August.

Shares in Novo Nordisk (NOVOb.CO) fall around 5% after U.S. President Donald Trump on Thursday said the price of Novo’s best-selling weight-loss drug would be lowered and that negotiations over price changes would be swift

Nordnet analyst Per Hansen says “there is nothing new in the statements” and that prices will be lower

Novo’s Ozempic is one of the drugs that has been chosen for price negotiations, with Hansen saying the “price negotiations are still ongoing, and the results will probably be known in the coming months”

If losses hold, Novo shares will track worst day since August

### Related Stocks

- [NVO.US - Novo Nordisk AS](https://longbridge.com/en/quote/NVO.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Novo Nordisk CFO Karsten Munk Knudsen Sells Shares Worth Over DKK 8.3 Million | Novo Nordisk A/S announced that CFO Karsten Munk Knudsen sold 26,246 shares for DKK 8.3 million at DKK 315.60 each and 3 | [Link](https://longbridge.com/en/news/275652909.md) |
| Savvy Advisors Inc. Purchases 22,138 Shares of Novo Nordisk A/S $NVO | Savvy Advisors Inc. increased its stake in Novo Nordisk A/S by 83.0% in Q3, acquiring 22,138 shares, bringing its total  | [Link](https://longbridge.com/en/news/275761183.md) |
| Novo Nordisk to Manufacture Wegovy in Ireland Facility | Novo Nordisk to Manufacture Wegovy in Ireland Facility | [Link](https://longbridge.com/en/news/275789396.md) |
| Oppenheimer Asset Management Inc. Has $31.35 Million Stock Position in Novo Nordisk A/S $NVO | Oppenheimer Asset Management Inc. increased its stake in Novo Nordisk A/S by 14.4% in Q3, holding 565,007 shares valued  | [Link](https://longbridge.com/en/news/275287765.md) |
| Novo Nordisk Aims To Start Selling Its Weight-Loss Blockbuster Wegovy In Vials - Bloomberg News | NOVO NORDISK AIMS TO START SELLING ITS WEIGHT-LOSS BLOCKBUSTER WEGOVY IN VIALS - BLOOMBERG NEWS | [Link](https://longbridge.com/en/news/275654518.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.